Jane S. Ricciuti, RPh, MS

Disclosures

October 23, 2002

In This Article

Vaccines

Fluzone
(Preservative-Free Influenza Virus Vaccine) Intramuscular Injection

Manufacturer: Aventis

Drug Approval Classification: Biological License Application Supplement Approval (Approval Date: 9/4/02)

New Indication: The FDA approved Fluzone preservative-free influenza virus vaccine formulation in a single-dose product in 0.25-mL syringes for pediatric use (infants aged 6-35 months).

Fluzone (Preservative-Free Influenza Virus Vaccine) Labeling

Fluzone (Preservative-Free Influenza Virus Vaccine)

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....